Building a Risk Scoring Model for ARDS in Lung Adenocarcinoma Patients Using Machine Learning Algorithms
Journal of Cellular and Molecular Medicine · 2024
DOI: 10.1111/jcmm.70280 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2024. Verfasst von Erchun Hong und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency Medicine, Bengbu Third People's Hospital, Bengbu Medical University, Bengbu, Anhui Province, China. Hauptthemen laut MEDLINE: Machine Learning, Adenocarcinoma of Lung, Respiratory Distress Syndrome, Lung Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Department of Education of Anhui Province-Anhui Province Higher School Scientific Research Project, Bengbu Third People's Hospital affiliated with Bengbu Medical University-Culture Programme.
Abstract (Originalsprache)
Lung adenocarcinoma (LUAD), the predominant form of non‐small‐cell lung cancer, is frequently complicated by acute respiratory distress syndrome (ARDS), which increases mortality risks. Investigating the prognostic implications of ARDS‐related genes in LUAD is crucial for improving clinical outcomes. Data from TCGA, GEO and GTEx were used to identify 276 ARDS‐related genes in LUAD via differential expression analysis. Univariate Cox regression, consensus clustering and machine learning algorithms were used to develop a prognostic risk scoring model. Functional enrichment, immune infiltration analyses, copy number variations and mutational burdens were examined, and the results were validated at the single‐cell level. ARDS‐related genes significantly impact the prognosis of LUAD patients. A machine learning‐based risk scoring model accurately predicted survival rates. Functional enrichment and immune infiltration analyses revealed that these genes are primarily involved in cell cycle regulation and immune cell infiltration. Single‐cell expression data supported these findings, and the assessments of copy number variations and mutational burdens highlighted distinct genetic characteristics. This study establishes the prognostic relevance of ARDS‐associated genes in LUAD and provides potential biomarkers for personalized therapy and prognosis. Future studies will validate these findings and explore their clinical applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Emergency Medicine, Bengbu Third People's Hospital, Bengbu Medical University, Bengbu, Anhui Province, China.
- Department of Neurology, Bengbu Third People's Hospital, Bengbu Medical University, Bengbu, Anhui Province, China.
- Department of Pathology, Bengbu Medical University, Bengbu, Anhui Province, China.
ORCID-Profile: Liang Zhang
Förderung
- Department of Education of Anhui Province-Anhui Province Higher School Scientific Research Project
- Bengbu Third People's Hospital affiliated with Bengbu Medical University-Culture Programme
Zitieren
APA
Hong, E., Sun, Y., Qin, Y., Zhao, W., Qin, Y., Li, X., & Zhang, L. (2024). Building a Risk Scoring Model for ARDS in Lung Adenocarcinoma Patients Using Machine Learning Algorithms. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70280
Vancouver
Hong E, Sun Y, Qin Y, Zhao W, Qin Y, Li X, et al. Building a Risk Scoring Model for ARDS in Lung Adenocarcinoma Patients Using Machine Learning Algorithms. Journal of Cellular and Molecular Medicine. 2024. doi:10.1111/jcmm.70280
BibTeX
@article{Hong2024,
author = {Hong, Erchun and Sun, Yunyun and Qin, Yongming and Zhao, Wenjun and Qin, Yanzi and Li, Xincan and Zhang, Liang},
title = {Building a Risk Scoring Model for ARDS in Lung Adenocarcinoma Patients Using Machine Learning Algorithms},
journal = {Journal of Cellular and Molecular Medicine},
year = {2024},
doi = {10.1111/jcmm.70280}
}
EUVIMED